These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5890840)

  • 1. On the role of drug penetration in amethopterin resistance of Sarcoma-180 cells in vitro.
    Hakala MT
    Biochim Biophys Acta; 1965 May; 102(1):198-209. PubMed ID: 5890840
    [No Abstract]   [Full Text] [Related]  

  • 2. On the nature of permeability of sarcoma-180 cells to amethopterin in vitro.
    Hakala MT
    Biochim Biophys Acta; 1965 May; 102(1):210-25. PubMed ID: 5294407
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of folate reductases of sarcoma 180 cells, sensitive and resistant to amethopterin.
    Raunio RP; Hakala MT
    Mol Pharmacol; 1967 May; 3(3):279-83. PubMed ID: 6068342
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical and pharmacologic properties of a new folate analog, 10-deaza-aminopterin, in mice.
    Sirotnak FM; DeGraw JI; Chello PL; Moccio DM; Dorick DM
    Cancer Treat Rep; 1982 Feb; 66(2):351-8. PubMed ID: 7055818
    [No Abstract]   [Full Text] [Related]  

  • 5. Further evidence for a basis of selective activity and relative responsiveness during antifolate therapy of murine tumors.
    Sirotnak FM; Donsback RC
    Cancer Res; 1975 Jul; 35(7):1737-44. PubMed ID: 1169115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific protection of folate reductase against chemical and proteolytic inactivation.
    Hakala MT; Suolinna EM
    Mol Pharmacol; 1966 Sep; 2(5):465-80. PubMed ID: 6008166
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhanced polyglutamylation of aminopterin relative to methotrexate in the Ehrlich ascites tumor cell in vitro.
    Matherly LH; Voss MK; Anderson LA; Fry DW; Goldman ID
    Cancer Res; 1985 Mar; 45(3):1073-8. PubMed ID: 2578870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of sensitivity and natural resistance to antifolates in a methylcholanthrene-induced rat sarcoma.
    Li WW; Lin JT; Schweitzer BI; Bertino JR
    Mol Pharmacol; 1991 Nov; 40(5):854-8. PubMed ID: 1719370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive dihydrofolate reductase binding assay of triazinate (NSC-139105), methasquin (NSC-122870), and aminopterin (NSC739).
    Myers CE; Eliot HM; Chabner BA
    Cancer Treat Rep; 1976 May; 60(5):615-6. PubMed ID: 1033031
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies on the transport of aminopterin, methotrexate, and methasquin by the L1210 leukemia cell.
    Sirotnak FM; Donsbach RC
    Cancer Res; 1972 Oct; 32(10):2120-6. PubMed ID: 4404161
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence and properties of dihydrofolate reductases within the genus Trypanosoma.
    Gutteridge WE; Jaffe JJ; McCormack JJ
    Br J Pharmacol; 1968 Sep; 34(1):191P-192P. PubMed ID: 4300138
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of dihydrofolate reductase from a methotrexate-resistant subline of human KB cells and comparison with enzyme from KB parent cells and mouse S180 AT/3000 cells.
    Domin BA; Cheng YC; Hakala MT
    Mol Pharmacol; 1982 Jan; 21(1):231-8. PubMed ID: 7132960
    [No Abstract]   [Full Text] [Related]  

  • 13. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue pharmacokinetics, inhibition of DNA synthesis and tumor cell kill after high-dose methotrexate in murine tumor models.
    Sirotnak FM; Donsbach RC; Dorick DM; Moccio DM
    Cancer Res; 1976 Dec; 36(12):4672-8. PubMed ID: 1000510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug response, dihydrofolate reductase, and cytogenetics of amethopterin-resistant Chinese hamster cells in vitro.
    Biedler JL; Albrecht AM; Hutchison DJ; Spengler BA
    Cancer Res; 1972 Jan; 32(1):153-61. PubMed ID: 5007683
    [No Abstract]   [Full Text] [Related]  

  • 16. Number of binding sites and possible mechanisms of action.
    Condit PT
    Ann N Y Acad Sci; 1971 Nov; 186():363-4. PubMed ID: 4943807
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for a genetic alteration of dihydrofolate reductase associated with amethopterin resistance in Diplococcus pneumoniae.
    Sirotnak FM; Donati GJ; Hutchison DJ
    Biochem Biophys Res Commun; 1964; 14():292-5. PubMed ID: 4378682
    [No Abstract]   [Full Text] [Related]  

  • 18. Defective transport of aminopterin in relation to development of resistance in Yoshida sarcoma cells.
    Braganca BM; Divekar AY; Vaidya NR
    Biochim Biophys Acta; 1967; 135(5):937-46. PubMed ID: 6065687
    [No Abstract]   [Full Text] [Related]  

  • 19. The recovery of liver tetrahydrofolate dehydrogenase activity from inhibition by methotrexate.
    Stanley BG; Neal GE; Williams DC
    Biochem Pharmacol; 1969 Jan; 18(1):159-71. PubMed ID: 5780985
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydrofolate reductase in Pediococcus cerevisiae strains susceptible and resistant to amethopterin.
    Mandelbaum-Shavit F; Grossowicz N
    Antimicrob Agents Chemother; 1974 Sep; 6(3):369-71. PubMed ID: 15830489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.